Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Probiotics play a vital role in supporting the immune system by strengthening gut health, regulating inflammation, and ...

SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a ...

Episode 4 of "Feel G.O.O.D. Gut Health Program" discusses the differences between IgE-mediated food allergies and IgG/IgA-mediated food sensitivities, and how to identify common symptoms like bloating ...

The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying ...

Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

By Rayk Riechmann As one of the brightest emerging biotechnology companies, Climb Bio Inc. (NASDAQ: CLYM) aims to improve the ...

ZyVersa Therapeutics (NASDAQ:ZVSA – Get Free Report) is expected to be announcing its earnings results before the market ...

New study results presented at the European Lung Cancer Congress (ELCC) 2025, March 26 to 29, demonstrate the role of AstraZeneca's TAGRISSO® (osimertinib), as monotherapy and as the backbone for ...

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

Novartis wins FDA approval for the label expansion of Fabhalta for a third indication - treatment of adults with C3 ...

Identifying antibodies for 75% of norovirus outbreaks, University researchers took a step forward in creating a vaccine for ...